The popularity of Viagra initially drove a surge for pharma, however recent developments present a complicated scenario for investors. Lower-cost versions are reducing earnings, and continued litigation add more risk https://anitaehbb835846.howeweb.com/41824772/viagra-and-the-pharmaceutical-industry-a-volatile-play